Cell adhesion and regulatory molecules involved in tumor formation, hemostasis, and wound healing
- 1 March 1995
- journal article
- review article
- Published by Wiley in Head & Neck
- Vol. 17 (2) , 140-147
- https://doi.org/10.1002/hed.2880170212
Abstract
Background. Dynamic changes in cell adhesion and migration are fundamental properties of the cells that are important in hemostasis, vascularization, and wound repair. Changes in cell adhesion and migration are very important in the formation of tumors, and invasion and metastasis by neoplasms. Methods. Using immunolocalization and immunopurification techniques, expression of integrin molecules involved in cell adhesion has been characterized during tumor development and wound healing. The ability of cytokines to regulate expression and antibody and peptide inhibitors to inhibit function of integrins has been explored to better understand the role of integrins in pathogenesis. Results. Increased suprabasilar expression of the integrins α6β4, α2β1, and α3β1 accompanies development of squamous cell neoplasms of the head and neck. Integrin αllβ3 is an integrin receptor which is important in platelet aggregation in hemostasis and formation of tumor metastases. Increased expression of integrin αvβ3 has been identified in angiogenesis in response to growth factors and tumor angiogenic factors. Cytokine TGF‐β and arachadonic acid metabolite 12(S)‐HETE are important signals in regulation of integrins and affect cell aggregation and migration in these processes. Ligands and inhibitors for some of these receptors have been identified which will be useful in determining their role during tumor development and progression. Conclusions. Recent advances in understanding the functions of the integrin cell adhesion molecules may soon add new diagnostic methods and therapies to the armamentarium of the head and neck oncologic, microvascular, plastic, and reconstructive surgeon. Therapies directed at controlling integrin cell‐adhesion molecule expression and function are being explored to improve scar formation, bone synthesis, inhibition of vascular occlusion, and inhibition of tumor invasion and metastasis. © 1995 Jons Wiley & Sons, Inc.Keywords
This publication has 9 references indexed in Scilit:
- Requirement of Vascular Integrin α v β 3 for AngiogenesisScience, 1994
- Antiplatelet and antithrombotic efficacy of DMP 728, a novel platelet GPIIb/IIIa receptor antagonist.Circulation, 1994
- The integrin alpha 6 beta 4 is a laminin receptor.The Journal of cell biology, 1992
- Integrins: Versatility, modulation, and signaling in cell adhesionCell, 1992
- Control of scarring in adult wounds by neutralising antibody to transforming growth factor βThe Lancet, 1992
- The lipoxygenase metabolite 12(S)‐hete induces a cytoskeleton‐dependent increase in surface expression of integrin αiibβ3 on melanoma cellsInternational Journal of Cancer, 1991
- Altered Antigen Expression Predicts Outcome in Squamous Cell Carcinoma of the Head and NeckJNCI Journal of the National Cancer Institute, 1990
- Human colon carcinoma cells use multiple receptors to adhere to laminin: involvement of alpha 6 beta 4 and alpha 2 beta 1 integrins.Cell Regulation, 1990
- Identification of multiple cell adhesion receptors for collagen and fibronectin in human fibrosarcoma cells possessing unique alpha and common beta subunits.The Journal of cell biology, 1987